Main
>
ONCOLOGY (**)
>
Breast Cancer>HER2+>MET ***
>
Treatment
>
USA. P. Neratinib+Capecitabine>
>
(*) USA Approval Date: 2020. 02.26.
(*) USA Approval Date: 2020. 02.26.'s products
This section has no products